Long-term health-related quality of life in chronic hepatitis B patients.
- Author:
Gui-cheng WU
1
;
Wei-ping ZHOU
;
You-rong ZHAO
;
Shu-hua GUO
;
Zhi-yi WANG
;
Shu-bi ZOU
;
Quan-hai ZHANG
;
Hong REN
;
Ai-long HUANG
;
Ding-feng ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Antiviral Agents; therapeutic use; Cost of Illness; Female; Follow-Up Studies; Hepatitis B, Chronic; drug therapy; economics; Humans; Male; Middle Aged; Quality of Life; Surveys and Questionnaires
- From: Chinese Journal of Hepatology 2003;11(5):275-277
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate their long-term outcome and the efficacy and economic significance of antiviral drugs by investigating the long-term health-related quality of life (HQL) in chronic hepatitis B (CHB) patients.
METHODSThe HQL of 101 CHB patients with biopsy-proven 6 to 18 years ago and 105 persons of general population as control was studied with revised SF-36 questionnaire.
RESULTSThe HQL in CHB patients was lower than that in general population in physical functioning, role physical, general health, mental health, and specific symptoms (mu > or = 2.10, P<0.05).
CONCLUSIONSThe long-term HQL in chronic hepatitis B patients is poor.
